Results 121 to 130 of about 8,856 (141)

Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease. [PDF]

J Bras Nefrol
Distenhreft JIQ, Couto-Lima D, Andreazzi CS, Thomazini JFRC, Vasconcellos Filho LM, Falqueto A, Luchi WM.   +6 more
europepmc   +1 more source

Burden of Liver Cirrhosis in Portugal between 2010 and 2017. [PDF]

GE Port J Gastroenterol, 2021
Silva JM, Silva MJ, Calinas F, Nogueira PJ.   +3 more
europepmc   +1 more source

Glomerulopathy associated with schistosomiasis mansoni. [PDF]

J Bras Nefrol
Pontes IBS, Duarte Neto AN, Dias CB.
europepmc   +1 more source

Five-Year Sustained Response to Nivolumab in Hepatocellular Carcinoma following Serious Immune-Related Hepatitis. [PDF]

GE Port J Gastroenterol
Mendes JL, Spencer AS, Pimentel JC, Sardinha M, Ferreira JB, da Luz R.   +5 more
europepmc   +1 more source

RENAL INJURY AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IN PATIENTS WITH OBESITY. [PDF]

Arq Gastroenterol
Carvalho KD, Daltro C, Daltro C, Cotrim HP.   +3 more
europepmc   +1 more source

Buschke-Löwenstein Tumor: An Unusual Therapeutic Approach. [PDF]

GE Port J Gastroenterol
Gonçalves R, Garrido I, Coelho R, Coelho R, Lopes J, Macedo G.   +5 more
europepmc   +1 more source

Troponin I is an independent marker of cardiovascular mortality risk in chronic kidney disease patients. [PDF]

J Bras Nefrol
Romaniello G, Hayashi SY, Guerra BS, Riella MC, Lindholm B, Marques GL, Nascimento MMD.   +6 more
europepmc   +1 more source

Autoimmune Hepatitis Induced by Hepatitis Delta Virus: A Conundrum. [PDF]

GE Port J Gastroenterol
Cardoso MF, Carvalho R, Correia FP, Branco JC, Costa MN, Martins A.   +5 more
europepmc   +1 more source

Health technology assessment in the Brazilian National Health System: profile of CONITEC exclusion recommendations, 2012-2023. [PDF]

Epidemiol Serv Saude
Pinheiro FS, Borges SS, Rodrigues FD.
europepmc   +1 more source

C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: a diagnostic and therapeutic challenge. [PDF]

J Bras Nefrol
Beirão B, Freitas M, Silva N, Ferraz P, Prata C, Morgado T.   +5 more
europepmc   +2 more sources